CC0000: Color is not claimed as a feature of the mark.
D10000: "(OPICAPONE) CAPSULES"
DM0000: The mark consists of the stylized wording "ONGENTYS (OPICAPONE) CAPSULES" combined with a design of two curved lines.
GS0051: PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISEASES AND DISORDERS OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM, MOVEMENT DISORDERS, PARKINSON'S DISEASE AND PARKINSONIAN DISORDERS, AND RESTLESS LEGS SYNDROME
PM0001: ONGENTYS OPICAPONE CAPSULES
Case File Event Statements
1/18/2022 - 2 years ago
20 - REGISTERED-PRINCIPAL REGISTERType:R.PR
12/17/2021 - 3 years ago
19 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILEDType:SUNA
12/16/2021 - 3 years ago
18 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTEDType:CNPR
12/16/2021 - 3 years ago
17 - STATEMENT OF USE PROCESSING COMPLETEType:SUPC
11/12/2021 - 3 years ago
16 - USE AMENDMENT FILEDType:IUAF
12/13/2021 - 3 years ago
15 - CASE ASSIGNED TO INTENT TO USE PARALEGALType:AITU
11/12/2021 - 3 years ago
14 - TEAS STATEMENT OF USE RECEIVEDType:EISU
5/11/2021 - 3 years ago
13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
3/16/2021 - 3 years ago
12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
3/16/2021 - 3 years ago
11 - PUBLISHED FOR OPPOSITIONType:PUBO
2/24/2021 - 3 years ago
10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
2/5/2021 - 3 years ago
9 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
2/5/2021 - 3 years ago
8 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
2/5/2021 - 3 years ago
7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
2/5/2021 - 3 years ago
6 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
2/5/2021 - 3 years ago
5 - EXAMINERS AMENDMENT -WRITTENType:CNEA
2/1/2021 - 3 years ago
4 - ASSIGNED TO EXAMINERType:DOCK
10/28/2020 - 4 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILEDType:MDSM
10/27/2020 - 4 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAMType:NWOS